FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products... Show more
Faraday Future is positioning itself as an early mover in embodied AI (EAI), a category that applies artificial intelligence to physical machines such as humanoid and bionic robots. Management describes a "Device-Data-Brain" flywheel, in which deployed robots collect real-world data that continuously improves the underlying AI model, which in turn enhances future products. The company has stated it is among the first U.S. firms to deliver both humanoid and bionic robots, and it frames its robotics segment as a relatively asset-light growth engine that requires far less capital than scaling an electric vehicle business.
Structurally, the company retains two product tracks. The FX brand, anchored by the Super One multi-purpose vehicle, targets the mainstream EV market with phased delivery plans, while the robotics division — spanning education, security, industrial, and commercial use cases — is expected to drive near-term revenue. This dual-track approach offers optionality, but it also stretches a balance sheet that ended the second quarter of 2026 with roughly $53.9 million in cash (about $11.2 million unrestricted) against approximately $114 million in debt.
Several near-term events could shape investor sentiment. The most immediate is the company's next earnings report, which is expected around November 11, 2026, and will clarify whether the robotics shipment trajectory toward the 2,000-unit full-year target remains on track. Equally significant is the proposed combination with FF EAI Robotics Ecosystem (FFR), a transaction management has indicated could close as soon as November 26, 2026, and which the company says would sharpen its robotics-focused identity and capital roadmap.
Other catalysts include the phased homologation and delivery of the FX Super One, progress toward domestic U.S. assembly at the Hanford, California facility (targeted for early 2027), and the rollout of software and ecosystem revenue on top of device sales. On the analyst front, Litchfield Hills Research has reiterated a Buy rating with a $66 price target, while Emerging Growth Research has maintained a "Buy–Emerging" rating with a $30 target, reflecting a wide spread in assumptions about execution risk and dilution. Consensus recommendation data shows the two covering analysts clustered at "Outperform," suggesting modestly constructive but not uniformly bullish sentiment.
The company's trajectory is closely tied to the pace of physical AI and robotics adoption, which remains a capital-intensive and rapidly evolving field dominated by better-funded rivals. Interest rates and the cost of capital matter acutely here: Faraday Future has historically depended on convertible debt and equity issuance, so a higher-for-longer rate environment could raise financing costs and amplify dilution risk. Inflation and supply-chain dynamics also influence the cost of imported components and OEM manufacturing.
Geopolitics and trade policy represent a meaningful swing factor. The company relies on Chinese OEMs for its robotics products, exposing it to tariff uncertainty and potential restrictions on imported robotics goods — risks the company itself flags in regulatory filings. Conversely, a shifting U.S. policy emphasis on domestic robotics manufacturing and compliance could, in the company's view, favor a "Built in USA" localization strategy. The competitive EV landscape adds another layer, as mainstream electric vehicle pricing pressure could complicate the FX program's economics.
Investors tracking Faraday Future's evolving story can use Tickeron's Trend Prediction Engine, an AI-powered forecasting tool that helps traders assess whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. The tool is designed to help users spot developing trends, evaluate potential breakouts or reversals, and explore predictions across a broad universe of tradable instruments. It includes searchable prediction categories, historical context, and alert-oriented functionality to support timely decision-making. As FF's robotics pivot continues to unfold, the Trend Prediction Engine can serve as a practical companion for monitoring shifts in market positioning and momentum.
Looking into 2026 and beyond, the company's narrative hinges on whether its robotics business can convert early shipment momentum into durable, higher-margin revenue. Management has outlined a five-year plan that projects revenue scaling from roughly $7 million in 2026 toward approximately $45 million in 2027 and about $1 billion by 2030, with a shift toward higher-value security, industrial, and commercial robots plus software revenue expected to lift gross margin over time. The company also targets U.S.-based production at Hanford beginning in early 2027, which could reduce import exposure and support compliance positioning.
Longer-term themes include the sustainability of positive product gross margin, the pace of software monetization, and disciplined capital allocation. The company has stated an objective of reducing total liabilities below $100 million within the next three to four quarters, while emphasizing that future funding decisions will aim to minimize dilution. Competitive threats from substantially better-capitalized humanoid robotics firms, regulatory developments, and continued negative cash flow remain the principal risks to the outlook. If consensus expectations remain anchored to execution milestones rather than near-term profitability, the stock's future path will likely be defined by delivery cadence, capital structure clarity, and the successful closing of the proposed robotics combination.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DIVO | 48.00 | -0.17 | -0.35% |
| Amplify CWP Enhanced Dividend Income ETF (DIVO) | |||
| SIXP | 34.56 | -0.24 | -0.69% |
| AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF (SIXP) | |||
| BEEX | 27.39 | -0.28 | -1.00% |
| Beehive ETF (BEEX) | |||
| IAUI | 46.59 | -1.16 | -2.43% |
| NEOS Gold High Income ETF (IAUI) | |||
| ACTS | 24.46 | -0.81 | -3.21% |
| FIS Tactical Equity ETF (ACTS) | |||
A.I.dvisor indicates that over the last year, FF has been loosely correlated with VHI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if FF jumps, then VHI could also see price increases.
a developer of specialty chemicals and biofuels
Industry ChemicalsSpecialty
The 10-day moving average for FF crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on FF as a result. In 73 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for FF just turned positive on October 12, 2026. Looking at past instances where FF's MACD turned positive, the stock continued to rise in 28 of 41 cases over the following month. The odds of a continued upward trend are 68%.
FF moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +8.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where FF advanced for three days, in 194 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The 10-day RSI Indicator for FF moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 29 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 78%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 54 cases where FF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
FF broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.582) is normal, around the industry mean (2.359). P/E Ratio (-9.200) is within average values for comparable stocks, (-17.286). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (1.548). Dividend Yield (0.007) settles around the average of (0.040) among similar stocks. P/S Ratio (1.553) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. FF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.